EUVIMED · CrossrefZeitschrift
Nature Reviews Clinical Oncology
ISSN 1759-4774 · Springer Science and Business Media LLC
Neueste Artikel
From the ESMO Congress 2026
Global landscape of early-onset breast cancer: from understanding risk to precision prevention and cancer interception
Cancer vaccines in the era of immunotherapy: from antigen delivery to immune ecosystem engineering
T cell redirection in high-risk smouldering multiple myeloma: can deep responses prevent progression to multiple myeloma?
Risvutatug rezetecan has promising efficacy in osteosarcoma
Divarasib outperforms first-generation KRAS-G12C inhibitors in NSCLC
Emerging strategies for paediatric cancer predisposition: detection, surveillance and prevention
Unprecedented OS with the addition of tarlatamab to first-line maintenance therapy for ES-SCLC
Author Correction: Combining locoregional treatments and immunotherapies in patients with unresectable hepatocellular carcinoma
Sacituzumab tirumotecan–pembrolizumab has efficacy in PD-L1-negative NSCLC
Reply to: ‘Interpreting surgical consolidation in oligometastatic gastro-oesophageal cancer’
Interpreting surgical consolidation in oligometastatic gastro-oesophageal cancer
Phase III data support a novel trifluridine–tipiracil dosing schedule
Exploring the landscape of targetable alterations in patients with glioblastoma
Combining locoregional treatments and immunotherapies in patients with unresectable hepatocellular carcinoma
Problematic control arms in National Cancer Institute myeloma trials
A modular framework for antibody–drug conjugate biomarkers
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics
Towards liquid biopsy-based analysis of antitumour immunity
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
Does ciltacabtagene autoleucel have a future in multiple myeloma?
The future is not always uniform: rethinking radiotherapy through spatial fractionation
Cancer burden and control in China: landscape, trends and challenges
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
Daraxonrasib effective in metastatic pancreatic ductal adenocarcinoma
Potential new standard of care for resectable gastro-oesophageal adenocarcinoma in Asia
Teclistamab monotherapy improves survival in RRMM
The future of ciltacabtagene autoleucel in multiple myeloma has just begun
Ciltacabtagene autoleucel heralds the arrival of fixed-duration therapies in myeloma
Emerging trends in the global burden of colorectal cancer
EUVIMED